MetLife Investment Management’s Opko Health OPK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $340K | Buy |
226,799
+22,061
| +11% | +$28.1K | ﹤0.01% | 2132 |
|
|
2026
Q1 | $233K | Buy |
204,738
+29,062
| +17% | +$35.8K | ﹤0.01% | 2153 |
|
|
2025
Q4 | $221K | Sell |
175,676
-31,499
| -15% | -$43.8K | ﹤0.01% | 2224 |
|
|
2025
Q3 | $321K | Sell |
207,175
-11,097
| -5% | -$15.2K | ﹤0.01% | 2041 |
|
|
2025
Q2 | $288K | Buy |
218,272
+54,042
| +33% | +$73.9K | ﹤0.01% | 1980 |
|
|
2025
Q1 | $273K | Sell |
164,230
-37,935
| -19% | -$62.5K | ﹤0.01% | 2027 |
|
|
2024
Q4 | $297K | Buy |
202,165
+58,589
| +41% | +$89.6K | ﹤0.01% | 2077 |
|
|
2024
Q3 | $214K | Sell |
143,576
-43,617
| -23% | -$64.7K | ﹤0.01% | 2256 |
|
|
2024
Q2 | $234K | Buy |
187,193
+7,605
| +4% | +$9.86K | ﹤0.01% | 2145 |
|
|
2024
Q1 | $216K | Sell |
179,588
-31,760
| -15% | -$31.8K | ﹤0.01% | 2166 |
|
|
2023
Q4 | $319K | Hold |
211,348
| – | – | ﹤0.01% | 1956 |
|
|
2023
Q3 | $338K | Hold |
211,348
| – | – | ﹤0.01% | 1867 |
|
|
2023
Q2 | $459K | Hold |
211,348
| – | – | ﹤0.01% | 1754 |
|
|
2023
Q1 | $309K | Buy |
211,348
+28,015
| +15% | +$36.1K | ﹤0.01% | 1938 |
|
|
2022
Q4 | $229K | Sell |
183,333
-31,048
| -14% | -$48.9K | ﹤0.01% | 2163 |
|
|
2022
Q3 | $405K | Hold |
214,381
| – | – | ﹤0.01% | 1789 |
|
|
2022
Q2 | $542K | Buy |
214,381
+8,085
| +4% | +$23.6K | ﹤0.01% | 1594 |
|
|
2022
Q1 | $710K | Buy |
206,296
+85,349
| +71% | +$301K | ﹤0.01% | 1553 |
|
|
2021
Q4 | $582K | Sell |
120,947
-19,559
| -14% | -$79.2K | ﹤0.01% | 1430 |
|
|
2021
Q3 | $513K | Buy |
140,506
+20,154
| +17% | +$75K | ﹤0.01% | 1506 |
|
|
2021
Q2 | $487K | Sell |
120,352
-31,506
| -21% | -$124K | ﹤0.01% | 1587 |
|
|
2021
Q1 | $651K | Buy |
151,858
+8,819
| +6% | +$42.1K | 0.01% | 1375 |
|
|
2020
Q4 | $565K | Sell |
143,039
-797
| -0.6% | -$3.33K | 0.01% | 1428 |
|
|
2020
Q3 | $531K | Sell |
143,836
-28,161
| -16% | -$119K | 0.01% | 1338 |
|
|
2020
Q2 | $587K | Hold |
171,997
| – | – | 0.01% | 1293 |
|
|
2020
Q1 | $230K | Buy |
171,997
+71,771
| +72% | +$112K | ﹤0.01% | 1618 |
|
|
2019
Q4 | $147K | Sell |
100,226
-65,252
| -39% | -$109K | ﹤0.01% | 2142 |
|
|
2019
Q3 | $346K | Buy |
165,478
+18,791
| +13% | +$38.4K | ﹤0.01% | 1622 |
|
|
2019
Q2 | $358K | Sell |
146,687
-293,374
| -67% | -$640K | ﹤0.01% | 1686 |
|
|
2019
Q1 | $1.15M | Buy |
440,061
+293,374
| +200% | +$888K | ﹤0.01% | 1583 |
|
|
2018
Q4 | $442K | Buy |
146,687
+22,045
| +18% | +$74.7K | 0.01% | 1444 |
|
|
2018
Q3 | $431K | Sell |
124,642
-25,526
| -17% | -$136K | ﹤0.01% | 1623 |
|
|
2018
Q2 | $706K | Buy |
+150,168
| New | +$570K | 0.01% | 1199 |
|
Other funds holding OPK
WCM
MetLife Investment Management's OPK Position: Q2 2026 in Review
MetLife Investment Management increased its Opko Health (OPK) stake by 11% in Q2 2026, buying an estimated $28.1K and bringing the position to 226,799 shares worth $340K. The position accounts for ﹤0.01% of the portfolio, ranked #2132.
MetLife Investment Management first reported a position in OPK in Q2 2018 and has held it in 33 quarters since. The position peaked at $1.15M in Q1 2019. 222 funds tracked by Wall St. Rank hold OPK as of Q2 2026.
- MetLife Investment Management held 226,799 shares of Opko Health worth $340K as of Q2 2026.
- MetLife Investment Management bought 22,061 Opko Health shares in Q2 2026, an estimated $28.1K.
- Opko Health made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2132 holding.
- MetLife Investment Management first reported a position in Opko Health in Q2 2018 and has held it in 33 quarters since.
- MetLife Investment Management's Opko Health position peaked at $1.15M in Q1 2019.
- 222 funds tracked by Wall St. Rank held Opko Health as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.